Lisa Wray
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Oncology 14
- CAR-T cell therapy research 11
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- Angela DeMichele (2 shared papers)Stephan A. Grupp (14 shared papers)Shannon L. Maude (11 shared papers)Allison Barz Leahy (11 shared papers)Regina M. Myers (11 shared papers)Amanda M. DiNofia (11 shared papers)Rosemarie Mick (1 shared paper)Yimei Li (10 shared papers)
- Journals
- Blood (6 papers)Transplantation and Cellular Therapy (5 papers)Biology of Blood and Marrow Transplantation (2 papers)Blood Advances (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Lisa Wray
18 papers receiving 412 citations
Peers
Comparison fields: 5 of 60
- Oncology 256
- Hematology 64
- Public Health, Environmental and Occupational Health 97
- Immunology 55
- Cancer Research 33
Countries citing papers authored by Lisa Wray
This map shows the geographic impact of Lisa Wray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Wray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Wray more than expected).
Fields of papers citing papers by Lisa Wray
This network shows the impact of papers produced by Lisa Wray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Wray. The network helps show where Lisa Wray may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Wray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. | 2003 | 134 |
| 2 | 2021 | 80 | |
| 3 | 2021 | 66 | |
| 4 | 2005 | 33 | |
| 5 | 2020 | 14 | |
| 6 | 2021 | 13 | |
| 7 | 2024 | 13 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 12 | |
| 10 | 2014 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2020 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2024 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2023 | 0 | |
| 20 | 2025 | 0 |
About Lisa Wray
Lisa Wray is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health and Genetics, having authored 22 papers that have together received 415 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Hematopoietic Stem Cell Transplantation (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Safe Handling of Antineoplastic Drugs (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Oncology (256 citations), Hematology (64 citations), Public Health, Environmental and Occupational Health (97 citations), Immunology (55 citations) and Cancer Research (33 citations). Lisa Wray has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Angela DeMichele, Stephan A. Grupp, Shannon L. Maude, Allison Barz Leahy, Regina M. Myers, Amanda M. DiNofia, Rosemarie Mick, Yimei Li, Edward A. Stadtmauer and Anne-Marie Martin. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Biology of Blood and Marrow Transplantation, Blood Advances and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.